Home > Boards > US Listed > Medical - Healthcare > Nxstage Medical, Inc. (NXTM)

NxStage Increases Revenue Guidance for Q4, expects to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mlkrborn Member Profile
 
Followed By 39
Posts 7,816
Boards Moderated 1
Alias Born 01/04/06
160x600 placeholder
mlkrborn   Monday, 01/13/14 05:02:19 PM
Re: None
Post # of 17 
NxStage Increases Revenue Guidance for Q4, expects to deliver total revenue of ~$69 mln, above the top end of its previously announced guidance range for revenue to be between $67-68.5 mln vs $67.7 mln Capital IQ Consensus Est. Co also expects net loss for Q4 to be within its previous announced guidance ranges of $5-6 mln ( NXTM ) : ...


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences